Matthew Gall
Director of Finance/CFO en ITEOS THERAPEUTICS, INC. .
Fortuna: 824 252 $ al 31/03/2024
Perfil
Matthew Gall is currently the Chief Financial Officer at iTeos Therapeutics, Inc. Prior to this, he worked as the Senior Vice President-Corporate Development at Sarepta Therapeutics, Inc. from 2014 to 2020.
He completed his undergraduate degree at Bowling Green State University and earned an MBA from The University of Chicago Booth School of Business.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
ITEOS THERAPEUTICS, INC.
0.17% | 07/03/2024 | 60 429 ( 0.17% ) | 824 252 $ | 31/03/2024 |
Cargos activos de Matthew Gall
| Empresas | Cargo | Inicio |
|---|---|---|
| ITEOS THERAPEUTICS, INC. | Director of Finance/CFO | 01/06/2020 |
Antiguos cargos conocidos de Matthew Gall.
| Empresas | Cargo | Fin |
|---|---|---|
| SAREPTA THERAPEUTICS, INC. | Corporate Officer/Principal | 01/06/2020 |
Formación de Matthew Gall.
| Bowling Green State University | Undergraduate Degree |
| The University of Chicago Booth School of Business | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| SAREPTA THERAPEUTICS, INC. | Health Technology |
| ITEOS THERAPEUTICS, INC. | Health Technology |
- Bolsa de valores
- Insiders
- Matthew Gall
